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Abstract
Inﬂuenza infection most commonly affects the upper and lower respiratory tracts, but can involve extrapulmonary sites, including the
myocardium. We report on a case of myocarditis caused by documented 2009 pandemic H1N1 inﬂuenza in a previously healthy adult,
and review the literature on inﬂuenza myocarditis.
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In September 2009, a 24-year-old African American female
who was healthy except for a history of benign cystic brain
lesion since childhood presented to our emergency depart-
ment with fatigue, light-headedness, dry cough, anorexia,
vomiting, rhinorrhoea, and weakness resulting in a fall. She
was afebrile, with a heart rate of 140 beats/min, a respiratory
rate of 21/min and a blood pressure of 74/50 mmHg supine
and 81/62 mmHg sitting. Physical examination showed nor-
mal mentation, clear lungs, and sinus tachycardia without
murmur or extra heart sounds. A chest radiograph, was nor-
mal and an echocardiogram showed only sinus tachycardia.
Other ﬁndings were as follows: white blood cell count,
12.7 000/mm3 (84.4% neutrophils and 10.9% lymphocytes);
serum creatinine, 0.7 mg/dL; alkaline phosphatase, 47 units;
aspartate transaminase, 19 units/L; alanine transaminase,
9 units/L; and total bilirubin, 0.3 mg/dL. The initial total crea-
tine phosphokinase (CPK) level was 204 units/L, and the tro-
ponin T level was 0.02 ng/mL. She was noted to be agitated,
and had two tonic–clonic seizures. She was admitted to the
intensive-care unit. A two-dimensional echocardiogram
showed marked global hypokinesis with a left ventricular
ejection fraction of 10–15% and a small to moderate, free-
ﬂowing pericardial effusion circumferential to the heart
(Fig. 1). A repeat echocardiogram showed low-voltage QRS,
diffuse ST elevation and sinus tachycardia (Fig. 2).
Past medical history was signiﬁcant for a brain cyst diag-
nosed at age 5 years with hydrocephalus and increased intra-
cranial pressure requiring one episode of drainage in
childhood. The patient had one episode of seizure at age
12 years. She had pre-eclampsia during pregnancy, and
underwent tubal ligation after delivery. She had no sick con-
tacts, or recent travel. She did not smoke, consume alcohol,
or use illicit drugs. Her 5-year-old and 1-year-old children
were healthy. She took no medications.
Droplet and contact isolation precautions were imple-
mented, according to the hospital infection control protocol.
The patient was started on oseltamivir oral solution 75 mg
twice daily for 5 days. A nasopharyngeal inﬂuenza A/B swab
(BD Directigen EZ Flu A+B Test) was positive for inﬂuenza A
virus, and this was conﬁrmed to be the 2009 pandemic H1N1
strain by the Massachusetts State Laboratory, using RT-PCR.
A head computed tomography scan conﬁrmed a known
2-cm cystic mass at the level of the foramen of Monro, with
hydrocephalus but no midline shift. A ventricular drain was
placed because of seizures and suspected intracranial hyperten-
sion, and mental status improved. A cerebral spinal ﬂuid (CSF)
sample contained 1 white blood cell per mm3, 73 red blood
cells per mm3, 5 mg/dL of total protein and 133 mg/dL of
glucose. CSF Gram stain showed no organisms and no growth
on culture. CSF enterovirus PCR ﬁndings were negative.
On day 2, a two-dimensional echocardiogram showed
persistent pericardial effusion with mild right atrial and
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ventricular collapse. An interventional radiologist was con-
sulted, but felt that there was there was insufﬁcient ﬂuid to
attempt drainage. A chest computed tomography scan
showed bilateral upper lobe scattered small patchy opacities,
and bilateral pleural effusions with adjacent atelectasis. The
patient developed respiratory failure, and was intubated and
mechanically ventilated in Assist-Control mode with 10-cm
H2O positive end-expiratory pressure. She required a nor-
epinephrine drip, owing to hypotension; stroke volume
(indexed) remained between 40 and 50 mL/m2, and ino-
tropes were not required. She developed a temperature of
38.7C.
On days 3–6, the echocardiogram did not change. Creati-
nine peaked at 2.1 mg/dL. CPK peaked on day 3 at
2693 units/L, with an MB fraction of 17.7 units/L. Troponin T
peaked at 0.31 ng/mL. On day 7, the ventricular drain was
clamped and removed. On day 8, the patient was extubated,
and a two-dimensional echocardiogram showed normaliza-
tion of left ventricular systolic function, reduced pericardial
effusion and pulmonary hypertension (estimated peak pres-
sure of 45 mmHg) with moderate to severe tricuspid valve
regurgitation. On day 12, she was discharged home without
neurological sequelae or the need for home oxygen supple-
mentation. Renal dysfunction, leukocytosis and the elevation
in CPK resolved.
Discussion
Inﬂuenza infection is commonly associated with pulmonary
complications, but may involve a number of other organ sys-
tems, including the myocardium. Our patient had clear evi-
dence of reversible myocardial dysfunction associated with
2009 pandemic H1N1 infection. She appears to have suffered
neurological consequences as well, although her history of
seizure disorder in childhood makes the association with
inﬂuenza less clear-cut.
Despite numerous case reports of myocarditis primarily
associated with inﬂuenza A, and an early study showing that
29% of inﬂuenza A patients had symptomless myocarditis by
electrocardiogram (EKG) criteria [1], the incidence of silent
myocardial involvement has been shown to be low when
CPK-MB fraction and troponin I and T levels are used as
diagnostic criteria [2]. In a study of 152 inﬂuenza patients,
none had elevated troponin levels, despite many patients
having elevated levels of CPK, presumably of skeletal muscle
origin [3]. Inﬂuenza RNA has been isolated from heart tissue
in patients with sudden, unexpected death, but other viruses
are more common [4].
The pathophysiology of inﬂuenza myocarditis, like that of
other types of viral myocarditis, includes both direct viral
invasion and an inﬂammatory reaction. In a murine model of
inﬂuenza A myocarditis, inﬂammatory cell inﬁltration of the
myocardium developed between days 3 and 7, and showed
healing by day 9. Platelet thrombi developed in the capillaries
FIG. 2. Echocardiogram showing mild
diffuse ST segment elevation in the pre-
cordial leads.
FIG. 1. Two-dimensional echocardiogram showing pericardial effu-
sion (arrow).
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between days 3 and 5, and left ventricular dysfunction was
shown between days 3 and 9, resolving by day 14. Electron
microscopy showed degenerating myosites, macrophages
and lymphocytes in close communication, implying that the
mechanism of injury involves both direct viral invasion and
cytotoxic immunological interactions [5].
Reports of myocarditis associated with 2009 pandemic
H1N1 appear to be extremely rare. One case series
described four children with fulminant myocarditis, with one
dying and two requiring extracorporeal membrane
oxygenation [6], and myocarditis was mentioned as a compli-
cation in ﬁve of 74 adult patients in one series examining
cases with severe disease and acute respiratory distress syn-
drome in China [7]. Seizures and other neurological compli-
cations have been well documented [8]. The 2009–2010
pandemic has been remarkable for the large number of
severe complications among young, previously healthy,
patients. Too few cases of myocarditis resulting from sea-
sonal inﬂuenza have been reported for risk factors to be
determined. However, in at least several reported cases, the
patients were young and otherwise healthy [9–12].
Treatment is largely supportive. Antiviral therapy is unpro-
ven, but might be helpful if started early. Immunosuppressive
therapy is unlikely to be helpful, and many patients will make
a full recovery within several weeks. For the remainder, the
mortality rate appears to be high [13].
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